[血细胞白血病患者的临床特征和生存分析]
Shi-Fang Wang1, Xiao-Qi Qin2, Qiao-Hua Guo1
1The Second Clinical Medical College of Shanxi Medical University,Taiyuan 030000, Shanxi Province, China.
Zhongguo shi yan xue ye xue za zhi
|June 25, 2023
概括
血细胞白血病 (PCL) 是一种具有多种症状的侵袭性癌症. 基于bortezomib的化疗可以提高PCL患者的治疗效率和存活时间,特别是那些患有初级PCL的患者.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 血细胞白血病 (PCL) 是一种罕见且具有攻击性的血液性恶性瘤.
- 了解其临床特征,治疗反应和预后对于改善患者的治疗结果至关重要.
研究的目的:
- 研究血细胞白血病 (PCL) 患者的临床特征,治疗反应和预后.
- 为了提高对这种具有挑战性的疾病的理解和管理.
主要方法:
- 在2010年至2019年期间治疗的27名PCL患者的回顾性分析.
- 分析了临床数据,实验室发现和治疗反应.
- 用Kaplan-Meier方法进行生存分析.
主要成果:
- 确定了18例初级PCL (pPCL) 和9例二次PCL (sPCL) 病例;中位数年龄为62.
- 常见的表现包括骨疼痛,疲劳和胀.
- 基于博尔特佐米布的化疗显示了52.9%的整体反应率.
- 平均存活时间为6.4个月;pPCL患者 (8.2个月) 的存活时间明显比sPCL患者 (2.4个月) 长.
结论:
- PCL具有高度侵入性,具有多种表现,对传统化疗敏感性较差.
- 初级PCL与二次PCL相比,提供相对较长的中位生存时间.
- 基于bortezomib的化疗方案提高了治疗效果,并延长了PCL患者的存活时间.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.8K
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
